155 related articles for article (PubMed ID: 25189640)
1. Chromosomal rearrangements and copy number abnormalities of TP63 correlate with p63 protein expression in lung adenocarcinoma.
Aubry MC; Roden A; Murphy SJ; Vasmatzis G; Johnson SH; Harris FR; Halling G; Knudson RA; Ketterling RP; Feldman AL
Mod Pathol; 2015 Mar; 28(3):359-66. PubMed ID: 25189640
[TBL] [Abstract][Full Text] [Related]
2. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.
Peterson JF; Pearce KE; Meyer RG; Greipp PT; Knudson RA; Baughn LB; Ketterling RP; Feldman AL
Histopathology; 2020 Feb; 76(3):481-485. PubMed ID: 31557339
[TBL] [Abstract][Full Text] [Related]
4. Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal.
DeCoste RC; Carter MD; Pasternak S; Fleming KE; Gaston D; Legge A; Ly TY; Walsh NM
Hum Pathol; 2021 Nov; 117():31-41. PubMed ID: 34391748
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of myb rearrangement detection and p63/p40 immunophenotyping in the diagnosis of adenoid cystic carcinoma of minor salivary glands: a pilot study.
Argyris PP; Wetzel SL; Greipp P; Wehrs RN; Knutson DL; Kloft-Nelson SM; García JJ; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):282-9. PubMed ID: 26711711
[TBL] [Abstract][Full Text] [Related]
6. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
7. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
[TBL] [Abstract][Full Text] [Related]
8. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
Rosenblum F; Hutchinson LM; Garver J; Woda B; Cosar E; Kurian EM
Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
[TBL] [Abstract][Full Text] [Related]
9. ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
Torres A; Alshalalfa M; Davicioni E; Gupta A; Yegnasubramanian S; Wheelan SJ; Epstein JI; De Marzo AM; Lotan TL
Prostate; 2018 Sep; 78(12):896-904. PubMed ID: 29761525
[TBL] [Abstract][Full Text] [Related]
10. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
Vogt AP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
[TBL] [Abstract][Full Text] [Related]
11. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
[TBL] [Abstract][Full Text] [Related]
12. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1.
Fielder T; Butler J; Tierney G; Holmes M; Lam KY; Satgunaseelan L; Colebatch AJ; Mahar A; Gupta R; O'Toole S; Cooper WA
Pathology; 2022 Jun; 54(4):399-403. PubMed ID: 34702583
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.
Vasmatzis G; Johnson SH; Knudson RA; Ketterling RP; Braggio E; Fonseca R; Viswanatha DS; Law ME; Kip NS; Ozsan N; Grebe SK; Frederick LA; Eckloff BW; Thompson EA; Kadin ME; Milosevic D; Porcher JC; Asmann YW; Smith DI; Kovtun IV; Ansell SM; Dogan A; Feldman AL
Blood; 2012 Sep; 120(11):2280-9. PubMed ID: 22855598
[TBL] [Abstract][Full Text] [Related]
14. ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.
Sholl LM; Sun H; Butaney M; Zhang C; Lee C; Jänne PA; Rodig SJ
Am J Surg Pathol; 2013 Sep; 37(9):1441-9. PubMed ID: 23887156
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma.
Roden AC; García JJ; Wehrs RN; Colby TV; Khoor A; Leslie KO; Chen L
Mod Pathol; 2014 Nov; 27(11):1479-88. PubMed ID: 24743219
[TBL] [Abstract][Full Text] [Related]
16. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.
Kim SK; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(3):1032-41. PubMed ID: 24696720
[TBL] [Abstract][Full Text] [Related]
17. On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.
Mescam-Mancini L; Lantuéjoul S; Moro-Sibilot D; Rouquette I; Souquet PJ; Audigier-Valette C; Sabourin JC; Decroisette C; Sakhri L; Brambilla E; McLeer-Florin A
Lung Cancer; 2014 Feb; 83(2):168-73. PubMed ID: 24380695
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
[TBL] [Abstract][Full Text] [Related]
19. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
